CSRC approved the registration of Chun Guang Group on the Growth Enterprise Market (GEM) IPO.
On March 6th, the China Securities Regulatory Commission issued the "Approval for the Initial Public Offering of Shares by Shandong Spring Sunshine Technology Group Co., Ltd."
On March 6th, the China Securities Regulatory Commission issued the approval for the initial public offering of shares of Shandong Jinhua Chunguang Technology Group Co., Ltd. It is reported that Chunguang Group plans to list on the Growth Enterprise Market of the Shenzhen Stock Exchange, with CICC as its sponsor institution, and intends to raise 750.71 million yuan.
According to the prospectus, the company is mainly engaged in the research, development, production, and sales of soft magnetic ferrite magnetic powders, and develops products such as soft magnetic ferrite cores, electronic components, and power sources along the industry chain. The various business segments of the company complement each other and promote each other, driving the synergistic and healthy development of the business, forming specific advantages in technology and industrial development within the industry.
The company's products are widely used in areas such as new energy vehicles and charging piles, smart homes and smart appliances, communication power supplies and communication equipment, green lighting, photovoltaic energy storage, Internet of Things, and medical fields. The products have entered the supply systems of well-known end customers, reflecting the company's comprehensive competitive advantages in production capacity, performance level, reliability, and other aspects.
Related Articles

PepsiCo, Inc. localizes over 90% of its raw materials to strengthen hedging against risks from GEO Group Inc

Zhejiang Starry Pharmaceutical (603520.SH) plans to acquire a 20% stake in Rui Shi Pharmaceutical for 10 million yuan to increase CMO production capacity.

Don't be scared by panic! The conflict in the Middle East has created a "golden buying opportunity". Are these two high-yield blue-chip stocks worth investing in with your eyes closed?
PepsiCo, Inc. localizes over 90% of its raw materials to strengthen hedging against risks from GEO Group Inc

Zhejiang Starry Pharmaceutical (603520.SH) plans to acquire a 20% stake in Rui Shi Pharmaceutical for 10 million yuan to increase CMO production capacity.

Don't be scared by panic! The conflict in the Middle East has created a "golden buying opportunity". Are these two high-yield blue-chip stocks worth investing in with your eyes closed?






